Stay updated on Trastuzumab Emtansine in HER2+ Tumors Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision labels updated: v3.4.3 added and v3.4.2 removed.
    Difference
    0.0%
    Check dated 2026-03-12T02:32:37.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the site, and the previous funding-status notice (v3.4.1) was removed.
    Difference
    0.4%
    Check dated 2026-02-11T14:25:01.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    New site-wide notice about lapse in government funding and NIH Clinical Center operations is now visible, and the page revision has been updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:30:25.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated page metadata labels (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act data') with a revision bump from v3.3.4 to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T06:24:09.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Added a site revision note: 'Revision: v3.3.4' and removed 'Revision: v3.3.3'; no study data, eligibility criteria, outcomes, or locations were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:21:54.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Locations now include Emilia-Romagna, Lombardy, Veneto, and Navarre, with a new revision tag v3.3.3. Corresponding region-specific location headings were adjusted from the previous version.
    Difference
    0.5%
    Check dated 2025-12-23T17:18:52.000Z thumbnail image

Stay in the know with updates to Trastuzumab Emtansine in HER2+ Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page.